Bioharvest Sciences BHST
NASDAQ BHST
$1.47 +0.02 (+1.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Bioharvest Sciences (BHST) Non-Current Debt (2024 - 2025)

Updated

Bioharvest Sciences (BHST) recorded Non-Current Debt of $2.1 million in the quarter ended Dec 31, 2025, down 51.5% from the prior quarter.

Analysis

Bioharvest Sciences (BHST) Non-Current Debt (2024 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Bioharvest Sciences reported Non-Current Debt of $12.4 million, up 262.9% from the prior year.

  • Across earlier years, Non-Current Debt came in at $3.42 million in the year ended Dec 31, 2024.
  • Per Business Quant, the preceding three quarters came in at $4.32 million (quarter ended Sep 30, 2025), $2.64 million (quarter ended Jun 30, 2025) and $3.34 million (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Bioharvest Sciences 26.70 Mn -43.69 Mn 5.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.10 Mn
Sep 30, 2025 4.32 Mn
Jun 30, 2025 2.64 Mn
Mar 31, 2025 3.34 Mn
Mar 31, 2024 3.34 Mn
API Access

Bioharvest Sciences Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=BHST&period=max&api_key=YOUR_API_KEY